Emmaus Life Valuation

EMMA Stock  USD 0.01  0.0001  0.71%   
Emmaus Life seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Emmaus Life Sciences from reviewing the firm fundamentals such as Shares Outstanding of 49.56 M, shares owned by insiders of 38.73 %, and Operating Margin of (0.65) % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
0.01
Please note that Emmaus Life's price fluctuation is out of control at this time. Calculation of the real value of Emmaus Life Sciences is based on 3 months time horizon. Increasing Emmaus Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Emmaus otc stock is determined by what a typical buyer is willing to pay for full or partial control of Emmaus Life Sciences. Since Emmaus Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Emmaus OTC Stock. However, Emmaus Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0139 Real  0.011 Hype  0.0154 Naive  0.0133
The real value of Emmaus OTC Stock, also known as its intrinsic value, is the underlying worth of Emmaus Life Sciences OTC Stock, which is reflected in its stock price. It is based on Emmaus Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Emmaus Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.01
Real Value
9.16
Upside
Estimating the potential upside or downside of Emmaus Life Sciences helps investors to forecast how Emmaus otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Emmaus Life more accurately as focusing exclusively on Emmaus Life's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Hype
Prediction
LowEstimatedHigh
0.000.029.17
Details
Naive
Forecast
LowNext ValueHigh
0.00030.019.17
Details

About Emmaus Life Valuation

The otc valuation mechanism determines Emmaus Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of Emmaus Life. We calculate exposure to Emmaus Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Emmaus Life's related companies.
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.

8 Steps to conduct Emmaus Life's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Emmaus Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Emmaus Life's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Emmaus Life's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Emmaus Life's revenue streams: Identify Emmaus Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Emmaus Life's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Emmaus Life's growth potential: Evaluate Emmaus Life's management, business model, and growth potential.
  • Determine Emmaus Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Emmaus Life's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Emmaus Life Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding49.3 M
Retained Earnings-241.3 M

Complementary Tools for Emmaus OTC Stock analysis

When running Emmaus Life's price analysis, check to measure Emmaus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emmaus Life is operating at the current time. Most of Emmaus Life's value examination focuses on studying past and present price action to predict the probability of Emmaus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emmaus Life's price. Additionally, you may evaluate how the addition of Emmaus Life to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years